Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Medical Countermeasures

Drinking Tea to Combat Ricin, Anthrax and C. diff

by Global Biodefense Staff
July 20, 2012

Researchers in Wales have identified properties in a common cup of tea that could help deactivate some bioterror agents and fight the hospital superbug Clostridium difficile.

The medicinal properties in tea have been widely known for centuries, and recent scientific research has shown tea to have antibacterial, anticancer and antiviral properties, thought to be due to a group of antioxidants called polyphenols.

Scientists from the Cardiff University School of Pharmacy and Pharmaceutical Sciences have found that Epigallocatechin gallate (EGCG), an ingredient in tea, is able to inactivate the highly-toxic substance ricin and inhibit the growth of the hospital superbug Clostridium difficile.

EGCG is the ester of epigallocatechin and gallic acid and is a type of catechin. The catechins are abundant in teas derived from the tea-plant Camellia sinensis as well as in some cocoas and chocolates.

Researchers at Cardiff University, working under Professor Les Baillie and in collaboration with the National Botanic Garden of Wales, have been working for several years to discover what components in tea are responsible for its disease-fighting antibacterial activity.

“We already knew that tea had the ability to inhibit anthrax – as long as it is black tea with no milk,” said Professor Baillie (Wales Online).  To examine the effects on a known superbug, the team exposed 79 strains of C.diff to 33 types of tea to see which proved best. Green tea appeared to have a stronger impact than black tea in tests.

“Over the last two years, we […] have been working out what chemical in tea are effective against the superbug and how exactly they work,” said William McCully, PhD student at Cardiff School. “Armed with this knowledge, we are trying to modify the growth conditions of a small plantation of Camellia sinensis plants this summer to produce a ‘super tea’ rich in polyphenols and high in antibacterial activity.”

The ultimate aim is to successfully produce a naturally enhanced tea that will be clinically effective for C. diff and potentially a wide-range of other biothreats.

Tags: AnthraxAntiviralsBioterrorismC. diffRicin

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC